Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

Serotyping of Streptococcus pneumoniaeby Coagglutination with 12 Pooled Antisera

M. K. Lalitha, Kurien Thomas, R. Satish Kumar, Mark C. Steinhoff, the IBIS Study Group†
M. K. Lalitha
Department of Clinical Microbiology and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kurien Thomas
Department of Medicine Unit II, Christian Medical College & Hospital, Vellore, India, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Satish Kumar
Department of Clinical Microbiology and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark C. Steinhoff
Department of International Health, School of Hygiene & Public Health, Johns Hopkins University, Baltimore, Maryland 21205
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
†
DOI: 10.1128/JCM.37.1.263-265.1999
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

We report on the performance of a recently introduced commercial chessboard method using 12 antisera, in comparison with that of the 55-antiserum panel used in determining the serogroups and types (SGTs) of Streptococcus pneumoniae, both of which were carried out by a coagglutination technique. Of a total of 150 strains of S. pneumoniae studied, 135 (90%) belonged to the SGTs represented in the 23-valent pneumococcal vaccine; of these, 130 (96.3%) were identified as the same SGTs by both typing methods. The remaining five strains showed cross-reactivity with more than two pools by the chessboard method, but could be assigned to a single SGT by the Quellung test. The 96.3% concordance of the chessboard method suggests it can be adopted for determination of the SGTs of S. pneumoniae in laboratories.

Streptococcus pneumoniaeis a common etiological agent of invasive diseases such as meningitis, septicemia, and pneumonia. There are 90 serotypes of S. pneumoniae (1), of which only a limited number cause most invasive disease in any given region (2). The currently available 23-valent pneumococcal vaccine (8) is comprised of about 90% of the types of S. pneumoniae isolated from invasive diseases. Serotyping of S. pneumoniae is important, because there have been changes in the rank order of types isolated from invasive diseases over a period of time in a single locality. This is important with reference to vaccine formulations (9, 11). Differences in the types that are isolated from different age groups (2) and regional differences in distribution of types have also been reported (9, 11). The Quellung reaction has been the “gold standard” method for typing of S. pneumoniae (5). The conventional method of serotypingS. pneumoniae uses pneumococcal typing antisera obtained from Statens Seruminstitut, Copenhagen, Denmark. It is comprised of nine pools, designated A to I, and 46 individual group- or type-specific antisera represented in the pools; thus a total of 55 antisera are required. The new chessboard system described consists of 12 pooled antisera designated A to H (except G and I) and P to T (G and I are not included in the pools, because they consist of nonvaccine serogroups or types [SGTs]) which comprise most of the SGTs that are included in the presently available 23-valent pneumococcal vaccine. Since the serotyping procedure using the 55-antiserum panel (3, 4) has been simplified by utilizing the coagglutination (COA) method, we report an assessment of the chessboard serotyping system by using the COA method.

S. pneumoniae cultures from blood, cerebrospinal fluid, and other body fluids of patients admitted to Christian Medical College (Vellore, Tamil Nadu, India) during a period of 6 months (from July 1996 to February 1997) as part of an ongoing Invasive Bacterial Infection Surveillance (IBIS) study and from other IBIS centers (Delhi and Nagpur) and the IBIS networking center (Pondicherry) were used in the study.

The 12 pools (A through H and P to T) of antisera (Table1) and the 55-antiserum panel comprised of 9 pools (A through H and I) and the individual 46 SGTs were obtained from Statens Seruminstitut, Copenhagen, Denmark. Cowan 1 staphylococcal cells used for sensitizing the antisera were prepared in the Department of Microbiology at Christian Medical College and Hospital, as described elsewhere (4). The COA reagents were prepared by sensitizing 10% of the staphylococcal cells with each of the 12 pooled antisera, and each was checked by using a known SGT isolate included in that particular pool for a positive reaction. Normal rabbit antiserum was used as the negative control.

View this table:
  • View inline
  • View popup
Table 1.

Pneumococcal types and groups reacting with the 12 pooled antiseraa

The bacterial isolates to be typed were subcultured onto Trypticase soy agar (Difco Laboratories, Detroit, Mich.) with 5% sheep blood and incubated in 5 to 10% CO2. Freshly isolated colonies were used for testing. The colonies were emulsified in normal physiological saline and the opacity was adjusted to MacFarland opacity 1. The serotyping was carried out by a rapid slide agglutination method (4). In a ceramic ring slide, 25 μl of the COA reagent was mixed with 25 μl of the cell suspension. The slide was gently rocked for 2 to 3 min and observed for clumping and clearance, the presence of which was taken as a positive reading. The pools in which the positive results were first noted were taken as the final reading.

The 12 pools were tested simultaneously and the two pools which gave positive results were used to identify the SGT of the strain with the help of the chart. For example, a strain that gave a positive result with pools A and P was identified as belonging to serotype 1. For comparison, all isolates were also tested in the nine pools A to I, and further typing was with antisera from the pool that gave the positive reaction. All tests were carried out independently and interpreted by two persons with neither observer being aware of the results of the other. The Neufeld Quellung test was done according to standard procedures (5). The objective of the Quellung test was to establish unequivocally the SGTs of those strains that were found to belong to either pool G or pool I by the chessboard method, which could identify only the pools and not the types or those which gave cross-reactions in more than two pools.

Of the total of 150 strains of S. pneumoniae studied, the SGTs of 135 strains (90%) were found to fall in the vaccine type category. One hundred thirty of them (96.3%) were identified as the same SGT by both the 55-antiserum panel and the chessboard method. The concordant SGTs were as follows (Table2): 1 (n = 39), 6 (n = 16), 7 (n = 11), 15 (n = 10), 5 and 9 (n = 8 each), 14 and 18 (n = 6 each), 12 (n = 4), and others, which included SGTs 2, 3, 8, 10, 11, 17, 19, 20, 23, and 33 (n = 22). Of the remaining 20 strains, 8 could not be serogrouped or typed by the chessboard method, because they belonged to pools G and I, which are not included in the 12 pools. Their serotypes were determined by the 55-antiserum panel typing method as 34 (n = 3), 35 (n = 3), 25 (n = 1), and 45 (n = 1).

View this table:
  • View inline
  • View popup
Table 2.

Distribution of pneumococcal SGTs

By the chessboard method, seven strains could be assigned only their pools, not their SGTs, because they also belonged to nonvaccine SGTs. Even in the pools that are included, not all of the SGTs are present; some are omitted, because they are not included in the presently available 23-valent pneumococcal vaccine, such as 24 (n = 3), 13 (n = 2), 21 (n = 1), and 39 (n = 1). Five strains gave cross-reactions by the chessboard method as well as by the 55-antiserum panel COA procedure. Perhaps, this could represent a technical error. However, the SGTs, as determined by the Quellung reaction, matched the SGT exhibiting the stronger reactivity. The SGTs as determined by the Quellung reaction are 12 (n = 2), 14 (n = 2), and 4 (n = 1).

There are various techniques described for serotyping of S. pneumoniae (6, 10). The Neufeld Quellung test is the recognized “gold standard” method. The high cost and the technical expertise required prohibit the adoption of this method for regular serotyping in the laboratory. The COA method has been standardized as an alternative method of serotyping (3, 4). Even by this method, the serogrouping or typing of S. pneumoniae by using the presently available panel of 55 antisera has its limitations, because it is a time-consuming procedure requiring expensive antisera. A newly described method consisting of 12 pooled antisera (7) was tested for its performance in comparison with the presently used panel of 55 antisera by the COA technique. To our knowledge, the 12 pooled antisera have not been evaluated by COA. Of the 150 strains tested, 135 belonged to the vaccine type category. One hundred thirty (96.3%) among them gave the same result by both of the typing procedures. As far as the 130 strains are concerned, the chessboard method was able to identify all of the strains that are included in the presently available 23-valent pneumococcal vaccine. The volume of COA reagent (i.e., Cowan 1 staphylococcal cells need to be prepared) will be less for the pool of 12 antisera than for the panel of 55 antisera. Identification of the SGTs of the strains in question is comparatively quicker and easier in the chessboard method, because it is done by a one-step procedure of referring to the chart (Table 1), which saves time, while in the typing method employing the 55-antiserum panel, all of the pools should be tried first, and then the individual types should be tested for the identification of the SGT of a strain. The introduction of this new system for the regular serogrouping or typing of S. pneumoniae in the laboratory must be done with the consideration of the prevalence of the SGTs of the organism in a particular region, because it does not identify the nonvaccine SGT. In a region in which there is a considerable heterogeneity in the prevalence of such nonvaccine SGTs, the conventional 55-antiserum panel for serogrouping or typing should be used for the confirmation of those strains that may not be confirmed by the chessboard method. However, the incidence of such a diverse group of strains in a particular region, which would make the serogrouping or typing of the isolate difficult, has been very insignificant. In the present study, the number of such strains encountered was only 10% of the total (15 strains). When the test is performed with a large number of strains, this percentage should be taken into consideration. Available data on the prevalence of such nonvaccine SGTs in a particular region should give an idea about implementing this new method for routine purposes in the laboratory. Subtyping of strains belonging to a type is not possible by the chessboard method the way it is in the conventional method. For example, it is possible to identify only group 18 and not its individual subtypes, 18A, 18B, 18C, and 18F. Hence, the concordance of the chessboard method with the conventional method is only to the level of the group. However, with important vaccine types, such as serotype 1, the comparison is directly related to the types.

The COA method has been described as being a good alternative for serotyping of S. pneumoniae (3, 4). The lower cost, simple procedure, and rapidity in obtaining a result by the COA method compared with the higher cost and technical expertise required for performing and interpreting the Quellung test, as found by the testing of 20 strains, support the earlier finding (3, 4). Thus, the chessboard method can be an equally good method to determine the SGTs of S. pneumoniae, which are included in the 23-valent pneumococcal vaccine. Strains giving negative results or cross-reactions may be further typed by conventional procedures.

ACKNOWLEDGMENTS

We acknowledge the United States Agency for International Development and International Clinical Epidemiology Network for financial support for the IBIS study, as a part of which the present study was made possible.

FOOTNOTES

    • Received 18 May 1998.
    • Returned for modification 18 August 1998.
    • Accepted 13 October 1998.
  • Copyright © 1999 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Henrichsen J.
    Six newly recognized types of Streptococcus pneumoniae.J. Clin. Microbiol.33199527592762
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Klein J. O.
    The epidemiology of pneumococcal disease in infants and children.Rev. Infect. Dis.31981246253
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Kronvall G.
    A rapid slide agglutination method for typing pneumococci by means of specific antibody absorbed to protein A containing staphylococci.J. Med. Microbiol.61973187190
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Lalitha M. K.,
    2. Pai R.,
    3. John T. J.,
    4. Thomas K.,
    5. Jesudason M. V.,
    6. Brahmadathan K. N.,
    7. Sridharan G.,
    8. Steinhoff M. C.
    Serotyping of Streptococcus pneumoniae by agglutination assays: a cost effective technique for developing countries.Bull. W. H. O.741996387390
    OpenUrlPubMedWeb of Science
  5. 5.↵
    1. Neufeld F.
    Über die Agglutination der Pneumokken und über die Theorieen der Agglutination.Z. Hyg. Infektionskr.4019025472
    OpenUrlCrossRef
  6. 6.↵
    1. Singhal A.,
    2. Lalitha M. K.,
    3. John T. J.,
    4. Thomas K.,
    5. Ragupathy P.,
    6. Jacob S.,
    7. Steinhoff M. C.
    Modified latex agglutination test for rapid detection of Streptococcus pneumoniae and H. influenzae in cerebrospinal fluid and direct serotyping of Streptococcus pneumoniae.Eur. J. Clin. Microbiol. Infect. Dis.151996472477
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Skov Sørensen U. B.
    Typing of pneumococci by using 12 pooled antisera.J. Clin. Microbiol.31199320972100
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Smit P.,
    2. Oberholzer D.,
    3. Hayden Smith S.,
    4. Koornhof H. J.,
    5. Hilleman M. R.
    Protective efficacy of pneumococcal polysaccharide vaccines.JAMA238197726132616
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Sniadack D. H.,
    2. Schwartz B.,
    3. Lipman H.,
    4. Bogaerts J.,
    5. Butler J. C.,
    6. Dagan R.,
    7. Echaniz-Abiles G.,
    8. Lloyd-Evans N.,
    9. Fenoll A.,
    10. Girgis N. I.,
    11. et al.
    Potential intervention for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children—implications for vaccine strategies.Pediatr. Infect. Dis. J.141995503510
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Sridharan G.,
    2. John T. J.,
    3. Lalitha M. K.,
    4. Harrison L. H.,
    5. Steinhoff M. C.
    Serotypes of Streptococcus pneumoniae causing meningitis in Southern India—use of new direct latex agglutination antigen detection test in cerebrospinal fluid.Diagn. Microbiol. Infect. Dis.181994211214
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Steinberg J. J.,
    2. Levine D. S.,
    3. Desiderio D.,
    4. Hanna B. A.
    Serotypes of Streptococcus pneumoniae recovered from a large urban hospital population: the Bellevue experience from 1973–1984.Lab. Med.191988741743
    OpenUrl
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Serotyping of Streptococcus pneumoniaeby Coagglutination with 12 Pooled Antisera
M. K. Lalitha, Kurien Thomas, R. Satish Kumar, Mark C. Steinhoff, the IBIS Study Group†
Journal of Clinical Microbiology Jan 1999, 37 (1) 263-265; DOI: 10.1128/JCM.37.1.263-265.1999

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Serotyping of Streptococcus pneumoniaeby Coagglutination with 12 Pooled Antisera
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Serotyping of Streptococcus pneumoniaeby Coagglutination with 12 Pooled Antisera
M. K. Lalitha, Kurien Thomas, R. Satish Kumar, Mark C. Steinhoff, the IBIS Study Group†
Journal of Clinical Microbiology Jan 1999, 37 (1) 263-265; DOI: 10.1128/JCM.37.1.263-265.1999
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

serotyping
Streptococcus pneumoniae

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X